Lyra Therapeutics, Inc.
LYRA
$0.0873
$0.00080.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.58M | 51.63M | 67.50M | 87.12M | 102.75M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.45M | 2.82M | 1.94M | 2.33M | 2.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 43.03M | 54.44M | 69.44M | 89.44M | 104.82M |
|
|
|||||
| Total Current Assets | 43.03M | 54.44M | 69.44M | 89.44M | 104.82M |
| Net Property, Plant & Equipment | 21.33M | 22.32M | 23.16M | 49.41M | 35.28M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.99M | 1.99M | 1.99M | 2.68M | 2.50M |
| Total Assets | 66.35M | 78.76M | 94.58M | 141.53M | 142.60M |
|
|
|||||
| Total Accounts Payable | 1.18M | 2.29M | 4.97M | 2.84M | 3.13M |
| Total Accrued Expenses | 2.11M | 3.20M | 6.10M | 10.06M | 8.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.12M | 4.00M | 4.27M | 4.50M | 5.43M |
| Total Finance Division Other Current Liabilities | 5.22M | 5.46M | 3.94M | 1.32M | 2.89M |
| Total Other Current Liabilities | 5.22M | 5.46M | 3.94M | 1.32M | 2.89M |
| Total Current Liabilities | 12.63M | 14.95M | 19.28M | 18.72M | 19.60M |
|
|
|||||
| Total Current Liabilities | 12.63M | 14.95M | 19.28M | 18.72M | 19.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.26M | 31.32M | 32.48M | 33.36M | 21.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.86M | 11.86M | 11.85M | 11.94M | 12.14M |
| Total Liabilities | 54.75M | 58.14M | 63.61M | 64.02M | 53.18M |
|
|
|||||
| Common Stock & APIC | 416.38M | 414.41M | 412.92M | 411.29M | 400.74M |
| Retained Earnings | -404.79M | -393.81M | -381.94M | -333.81M | -311.36M |
| Treasury Stock & Other | -- | 20.00K | -4.00K | 25.00K | 33.00K |
| Total Common Equity | 11.59M | 20.62M | 30.98M | 77.50M | 89.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.59M | 20.62M | 30.98M | 77.50M | 89.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.59M | 20.62M | 30.98M | 77.50M | 89.42M |
|
|
|||||